Mandar Deodhar

USPTO Granted Patents = 9 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Ashfield, AU (2013)
New South Wales, AU (2016 - 2018)
Frenchs Forest, AU (2020 - 2021)

Company Filing History:

Boehringer Ingelheim International Gmbh

Years Active: 2013-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428370 - Haloallylamine dual amine oxidase inhibitors (2025-09-30),

2. 12178791 - Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof (2024-12-31),

3. 11098045 - Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof (2021-08-24),

4. 10717734 - Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof (2020-07-21),

5. 10717733 - Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof (2020-07-21),

6. 10160723 - Substituted 3-haloallylamine inhibitors of SSAO and uses thereof (2018-12-25),

7. 9815782 - Substituted 3-haloallylamine inhibitors of SSAO and uses thereof (2017-11-14),

8. 9302986 - Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof (2016-04-05),

9. 8426587 - Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor (2013-04-23),

Title: Innovations of Mandar Deodhar

Introduction

Mandar Deodhar is an accomplished inventor based in Frenchs Forest, Australia. He holds a total of nine patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing novel compounds that target various neuromuscular and neuroinflammatory diseases.

Latest Patents

One of his latest patents is titled "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are particularly useful for treating a variety of neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases affecting both peripheral and central systems in humans, pets, and livestock.

Another significant patent is "Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof." This invention involves novel compounds that inhibit certain amine oxidase enzymes. These compounds are beneficial for treating various conditions, including fibrosis, cancer, and angiogenesis in both humans and animals. Additionally, this patent includes pharmaceutical compositions containing these compounds and outlines their various uses.

Career Highlights

Mandar Deodhar has worked with notable companies in the pharmaceutical industry, including Pharmaxis Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Jonathan Stuart Foot and Craig Ivan Turner. Their collaboration has likely enhanced the research and development efforts in their respective projects.

Conclusion

Mandar Deodhar's innovative work in developing compounds for treating serious medical conditions highlights his significant role as an inventor in the pharmaceutical field. His contributions continue to impact both human and animal health positively.

This text is generated by artificial intelligence and may not be accurate.